Product Categories
| Country: | China |
|---|---|
| Tel: | 022-20629054 |
| Mobile: | 15620629054 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Ruxolitinib | C17H18N6 | 941678-49-5 | Details |
| 4-AMino-5-Methylpyridin-2-ol | C6H8N2O | 95306-64-2 | Details |
| (6S,9R)-6-(2,3-Difluorophenyl)-6,7,8,9-tetrahydro- 9-[[tris(1-methylethyl)silyl]oxy]-5H-cyclohepta[b]pyridin-5-one；Rimegepant Impurity 14 | C25H33F2NO2Si | 1190363-46-2 | Details |
| 3-Methyl-1,2,4-thiadiazole-5-carbohydrazide | C4H6N4OS | 1375066-73-1 | Details |
| (3'S)-1',2',5,7-Tetrahydro-2'-oxospiro[6H-cyclopenta[b]pyridine-6,3'-[3H]pyrrolo[2,3-b]pyridine]-3-carboxylic acid；atogepant impurity 25 | C15H11N3O3 | 1375541-21-1 | Details |
| ethyl 2-(7-(benzyloxy)-1,2-dihydrocyclopenta[b]indol-3(4H)-ylidene)acetate | C22H21NO3 | 1318262-62-2 | Details |
| INDEX NAME NOT YET ASSIGNED | C12H21N3O6 | 2761879-36-9 | Details |
| Bursopoietin | C14H25N7O3 | 60267-34-7 | Details |
| 4-(chloromethyl)-1-cyclopentyl-2-(trifluoromethyl)benzene | C13H14ClF3 | 957208-65-0 | Details |
| Sparsentan (RE-021) | C32H40N4O5S | 254740-64-2 | Details |
| (9R)-9-hydroxy-6,7,8,9-tetrahydrocyclohepta[b]pyridin-5-one；Rimegepant Impurity 2 | C10H11NO2 | 1190363-44-0 | Details |
| tert-butyl ((3S,5S,6R)-6-methyl-2-oxo-5-(2,3,6-trifluorophenyl)piperidin-3-yl)carbamate；atogepant impurity 6 | C17H21F3N2O3 | 1456803-43-2 | Details |
| Acetic acid, 2-[2-(4-morpholinyl)-2-cyclopenten-1-ylidene]-, ethyl ester | C13H19NO3 | 380350-42-5 | Details |
| 1,2,4-Triazolo[4,3-a]pyrazine, 5,6,7,8-tetrahydro-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-, hydrochloride (1:1), (8R)- | C9H13ClN6S | 1682610-44-1 | Details |
| Ritlecitinib | C22H27N5O4S | 2192215-81-7 | Details |
| Ethyl 5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylate | C9H8ClN3O2 | 1224944-77-7 | Details |
| 2-Oxo-1-(4-piperidinyl)-2,3-dihydro -1H-imidazo[4,5-b]pyridine dihydrochloride；Rimegepant Impurity 23 | C11H15ClN4O | 781649-84-1 | Details |
| (R)-3-(4-broMo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile | C11H14BrN3 | 1146629-83-5 | Details |
| 4-[4-[4-(trifluoroMethoxy)phenoxy]piperidin-1-yl]phenol | C18H18F3NO3 | 681482-81-5 | Details |
| 1-((2S,5R)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one | C15H19N5O | 1792180-81-4 | Details |
| Sparsentan | C19H27BN2O6S | 415697-56-2 | Details |
| Tegafur；5-Fluoro-1-(tetrahydro-2-fuanyl)-2,4-(1H,3H)-pyrimidinedione | C8H9FN2O3 | 17902-23-7 | Details |
| (2'R,3S)-1-(tert-butyl)-7'-chloro-4'H-spiro[pyrrolo[2,3-b]pyridine-3,3'-[1,2]oxathiino[5,6-b]pyridin]-2(1H)-one 2'-oxide；atogepant impurity 31 | C18H18ClN3O | 1455358-14-1 | Details |
| 2,4-Dichloro-5-fluoropyrimidine | C4HCl2FN2 | 2927-71-1 | Details |
| Tolvaptan Sodium Phosphate | C26H27ClN2NaO6P | 942619-79-6 | Details |
| 2-(2,3,6-trifluorophenyl)acetic acid;atogepant impurity 1 | C8H5F3O2 | 114152-23-7 | Details |
| (2-bromo-5-chloropyridin-3-yl)methanol；atogepant impurity 17 | C6H5BrClNO | 1227585-65-0 | Details |
| (R)-2-Chloro-1-((2-methyloxiran-2-yl)methyl)-4-nitro-1H-imidazole | C7H8ClN3O3 | 681490-93-7 | Details |
| (4aS,9bR)-6-bromo-1H,2H,3H,4H,4aH,5H,9bH-pyrido[4,3-b]indole | C19H21BrN2O3 | 1059630-13-5 | Details |
| (2-(N-(4,5-dimethylisoxazol-3-yl)-N-(methoxymethyl)sulfamoyl)phenyl)boronic acid | C13H17BN2O6S | 415697-58-4 | Details |
| benzyl (3S,4S)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)pyrrolidine-1-carboxylate | C22H23N5O2 | 2095311-51-4 | Details |
| 8-((3R,4S)-4-ethyl-1-((2,2,2-trifluoroethyl)carbamoyl)pyrrolidin-3-yl)-N-(2,2,2-trifluoroethyl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine-3-carboxamide | C20H21F6N7O2 | 2715120-86-6 | Details |
| Rimegepant | C28H28F2N6O3 | 1289023-67-1 | Details |
| Fezolinetant | C16H15FN6OS | 1629229-37-3 | Details |
| (6bR,10aS)-Ethyl 3-methyl-2-oxo-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(9H)-carboxylate | C17H21N3O3 | 313369-25-4 | Details |
| 1-Azulenesulfonic acid, 3,8-dimethyl-5-(1-methylethyl)-, ethyl ester | C17H22O3S | 6223-36-5 | Details |
| 3-ethyl-8-((3R,4S)-4-ethylpyrrolidin-3-yl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine | C29H31N5O5S | 2270173-63-0 | Details |
| benzyl (3S,4S)-3-(N-(tert-butoxycarbonyl)-N-(5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-yl)glycyl)-4-ethylpyrrolidine-1-carboxylate | C34H39N5O7S | 2768445-17-4 | Details |
| N-(tert-butyl)-3-methylpyridin-2-amine；atogepant impurity 18 | C10H16N2 | 1235305-63-1 | Details |
| 4-(2,3-Dihydro-2-oxo-1H-imidazo[4,5-b]pyridin-1-yl)- 1-piperidinecarboxylic acid 1,1-dimethylethyl ester；Rimegepant Impurity 12 | C16H22N4O3 | 781649-87-4 | Details |
| Upadacitinib | C17H19F3N6O | 1310726-60-3 | Details |
| benzyl (3R,4S)-3-(N-(tert-butoxycarbonyl)-N-(5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-yl)glycyl)-4-ethylpyrrolidine-1-carboxylate | C34H39N5O7S | 1428243-27-9 | Details |
| 2-BroMo-5-tosyl-5H-pyrrolo[2,3-b]pyrazine,N-Tosyl-5-bromo-4,7-diazaindole | C13H10BrN3O2S | 1201186-54-0 | Details |
| Riociguat | C20H19FN8O2 | 625115-55-1 | Details |
| daprodustat,GSK1278863 | C19H27N3O6 | 960539-70-2 | Details |
| benzyl(2S,5R)-5-amino-2-methylpiperidine-1-carboxylate | C14H21ClN2O2 | 1207853-23-3 | Details |
| 4-bromo-3-ethoxymethyl-benzoic acid ethyl ester | C12H15BrO3 | 948349-66-4 | Details |
| Fluorocytosine；4-amino-5-fluoro-2(1h)-pyrimidinon | C4H4FN3O | 2022-85-7 | Details |
| Abemaciclib | C27H32F2N8 | 1231929-97-7 | Details |
| N-tert-butyl-L-serineisopropyl ester | C11H21NO5 | 955379-18-7 | Details |
| 7-(benzyloxy)-3-broMo-1,2- dihydronaphthalene | C17H15BrO | 722536-73-4 | Details |
| Finerenone；(4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide | C21H22N4O3 | 1050477-31-0 | Details |
| (4aS,9bR)-Ethyl 6-bromo-5-(2-(methylamino)-2-oxoethyl)-3,4,4a,5-tetrahydro-1H-pyrido[4,3-b]indole-2(9bH)-carboxylate | C17H22BrN3O3 | 2098497-32-4 | Details |
| 1-(2,3,6-trifluorophenyl)propan-2-one；atogepant impurity 4 | C9H7F3O | 1305324-34-8 | Details |
| Minoxidil | C9H15N5O | 38304-91-5 | Details |
| FD1 | C12H15FN2O4 | 62987-05-7 | Details |
| ((3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)pyrrolidin-1-yl)(1H-imidazol-1-yl)methanone | C18H19N7O | Details |
| 5-Fluorouracil | C4H3FN2O2 | 51-21-8 | Details |
| 1-Bromo-2,3-difluorobenzene；Rimegepant Impurity 4 | C6H3BrF2 | 38573-88-5 | Details |
| Ruxolitinib phosphate | C17H21N6O4P | 1092939-17-7 | Details |
| 4-Methyl-7H-pyrrolo[2,3-d]pyrimidine | C7H7N3 | 945950-37-8 | Details |
| Tenapanor HCl | C50H68Cl6N8O10S2 | 1234365-97-9 | Details |
| Ethyl Isocyanatoacetate | C5H7NO3 | 2949-22-6 | Details |
| 1-(tert-butyl)-3-((5-chloro-3-(hydroxymethyl)pyridin-2-yl)methyl)-3-hydroxy-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one;atogepant impurity 30 | C18H19Cl2N3O | 1455358-12-9 | Details |
| (5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl]4-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate | C28H30F2N6O7S | 1374024-48-2 | Details |
| N-ethyl-2-(4-formylphenyl)acetamide | C11H13NO2 | 2477812-42-1 | Details |
| 4-Bromo-3-(ethoxymethyl)benzoic acid | 2925576-60-7 | Details |
| N-(2-Bromo-5- methoxyphenyl)acetamide | C9H10BrNO2 | 123027-99-6 | Details |
| 4-Chloro-2,6-diaminopyrimidine | C4H5ClN4 | 156-83-2 | Details |
| 7,8-dihydro-5H-cyclohepta[b] pyridine-5,9(6H)-dione；Rimegepant Impurity 1 | C10H9NO2 | 39713-40-1 | Details |
| lumateperone (Tosylate) | C31H36FN3O4S | 1187020-80-9 | Details |
| (R)-9-((triisopropylsilyl)oxy) -6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-onehydrochloride；Rimegepant Impurity 3 | C19H31NO2Si | 1190363-45-1 | Details |
| ethyl 2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate(WXG02032) | C15H17NO3 | 1206124-13-1 | Details |
| Bumetanide | C17H20N2O5S | 28395-03-1 | Details |
| (S)-1'-(tert-butyl)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylic acid | C19H19N3O3 | 1455358-16-3 | Details |
| 3-Amino-4,5-dimethylisoxazole | C5H8N2O | 13999-39-8 | Details |
| Ethyl ((benzyloxy)carbonyl)glycinate | C12H15NO4 | 1145-81-9 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||